Trilogy Capital’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Sell
8,856
-250
-3% -$20.7K 0.03% 231
2026
Q1
$754K Buy
9,106
+796
+10% +$66.6K 0.03% 218
2025
Q4
$696K Buy
8,310
+400
+5% +$33.6K 0.03% 217
2025
Q3
$665K Sell
7,910
-35
-0.4% -$2.91K 0.03% 215
2025
Q2
$659K Hold
7,945
0.03% 207
2025
Q1
$650K Sell
7,945
-53
-0.7% -$4.29K 0.03% 199
2024
Q4
$642K Buy
7,998
+913
+13% +$74.5K 0.03% 207
2024
Q3
$593K Buy
7,085
+156
+2% +$12.8K 0.03% 209
2024
Q2
$554K Sell
6,929
-1,135
-14% -$90.1K 0.03% 210
2024
Q1
$649K Buy
+8,064
New +$647K 0.04% 174
2023
Q1
Sell
-157,140
Closed -$12.2M 274
2022
Q4
$12.2M Buy
157,140
+1,779
+1% +$137K 0.86% 40
2022
Q3
$11.8M Sell
155,361
-325
-0.2% -$26K 1.05% 26
2022
Q2
$12.5M Buy
155,686
+46
+0% +$3.75K 1.08% 26
2022
Q1
$13.4M Buy
155,640
+23,445
+18% +$2.08M 0.96% 34
2021
Q4
$12.3M Buy
132,195
+5,751
+5% +$538K 0.92% 37
2021
Q3
$11.9M Buy
126,444
+1,028
+0.8% +$98.1K 0.91% 37
2021
Q2
$12M Sell
125,416
-1,873
-1% -$176K 0.88% 37
2021
Q1
$11.8M Buy
127,289
+19,170
+18% +$1.82M 0.91% 38
2020
Q4
$10.5M Buy
108,119
+14,517
+16% +$1.4M 0.86% 38
2020
Q3
$8.97M Buy
93,602
+11,795
+14% +$1.13M 0.86% 35
2020
Q2
$7.87M Sell
81,807
-57,906
-41% -$5.33M 0.78% 39
2020
Q1
$12.7M Buy
139,713
+52,976
+61% +$4.82M 1.4% 24
2019
Q4
$7.94M Sell
86,737
-354
-0.4% -$32.3K 0.78% 38
2019
Q3
$7.99M Sell
87,091
-1,286
-1% -$116K 0.85% 36
2019
Q2
$7.91M Sell
88,377
-1,962
-2% -$172K 0.87% 34
2019
Q1
$7.85M Sell
90,339
-880
-1% -$74.6K 0.93% 28
2018
Q4
$7.56M Sell
91,219
-2,538
-3% -$209K 1.02% 29
2018
Q3
$7.83M Buy
93,757
+3,187
+4% +$267K 0.97% 28
2018
Q2
$7.56M Buy
90,570
+7,911
+10% +$662K 1.02% 28
2018
Q1
$7.01M Buy
82,659
+15,068
+22% +$1.29M 1.02% 28
2017
Q4
$5.91M Buy
+67,591
New +$5.92M 0.96% 27

Other funds holding VCIT

Trilogy Capital's VCIT Position: Q2 2026 in Review

Trilogy Capital reduced its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) stake by 2.7% in Q2 2026, selling an estimated $20.7K and leaving 8,856 shares worth $732K. The position accounts for 0.03% of the portfolio, ranked #231.

Trilogy Capital first reported a position in VCIT in Q4 2017 and has held it in 31 quarters since. The position peaked at $13.4M in Q1 2022. 1,352 funds tracked by Wall St. Rank hold VCIT as of Q2 2026.

  • Trilogy Capital held 8,856 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $732K as of Q2 2026.
  • Trilogy Capital sold 250 Vanguard Intermediate-Term Corporate Bond ETF shares in Q2 2026, an estimated $20.7K.
  • Vanguard Intermediate-Term Corporate Bond ETF made up 0.03% of Trilogy Capital's portfolio in Q2 2026, its #231 holding.
  • Trilogy Capital first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q4 2017 and has held it in 31 quarters since.
  • Trilogy Capital's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $13.4M in Q1 2022.
  • 1,352 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.